Product code JLS— Clinical Chemistry

IMMULITE PROGESTERONE

Classification name
Radioimmunoassay, Progesterone
Device class
Class 1
Regulation
21 CFR 862.1620
Advisory panel
Clinical Chemistry
Total cleared
57
First cleared
Most recent

Market context for product code JLS

FDA has cleared 57 devices under product code JLS between 1977 and 2004, filed by 43 applicant companies. No FDA device recalls reference this product code. Class I devices are low-risk and subject to FDA general controls; many Class I device types are exempt from 510(k) premarket notification.

Clearances per year

last 15 years

Top applicants under product code JLS

Recent clearances under product code JLS

Data sourced from openFDA. This site is unofficial and independent of the FDA.